Logo image of 27N0.DE

CANNOVUM CANNABIS AG (27N0.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:27N0 - DE000A37FUP2 - Common Stock

0.412 EUR
0 (-0.48%)
Last: 12/29/2025, 7:00:00 PM

27N0.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap951.72K
Revenue(TTM)1.80K
Net Income(TTM)-179.60K
Shares2.31M
Float0
52 Week High0.81
52 Week Low0.1
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.07
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2021-05-11
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


27N0.DE short term performance overview.The bars show the price performance of 27N0.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 60

27N0.DE long term performance overview.The bars show the price performance of 27N0.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40 -60

The current stock price of 27N0.DE is 0.412 EUR. In the past month the price decreased by -9.85%. In the past year, price increased by 27.16%.

CANNOVUM CANNABIS AG / 27N0 Daily stock chart

About 27N0.DE

Company Profile

27N0 logo image Cannovum Cannabis AG engages in the manufacture, sale, and distribution of medical cannabis. The company is headquartered in Berlin, Berlin. The company went IPO on 2021-05-11. The firm engages as a wholesaler, importer and manufacturer of cannabis-based medicines and provide patients in Germany with medical cannabis. The firm focuses on the import of medical cannabis, medical-scientific education and distribution for facilitated access to cannabis-based therapies.

Company Info

CANNOVUM CANNABIS AG

Rheinsberger Strasse 76/77

Berlin BERLIN DE

Employees: 0

27N0 Company Website

27N0 Investor Relations

Phone: 491785811701

CANNOVUM CANNABIS AG / 27N0.DE FAQ

Can you describe the business of CANNOVUM CANNABIS AG?

Cannovum Cannabis AG engages in the manufacture, sale, and distribution of medical cannabis. The company is headquartered in Berlin, Berlin. The company went IPO on 2021-05-11. The firm engages as a wholesaler, importer and manufacturer of cannabis-based medicines and provide patients in Germany with medical cannabis. The firm focuses on the import of medical cannabis, medical-scientific education and distribution for facilitated access to cannabis-based therapies.


Can you provide the latest stock price for CANNOVUM CANNABIS AG?

The current stock price of 27N0.DE is 0.412 EUR. The price decreased by -0.48% in the last trading session.


What is the dividend status of CANNOVUM CANNABIS AG?

27N0.DE does not pay a dividend.


What is the ChartMill rating of CANNOVUM CANNABIS AG stock?

27N0.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Where is CANNOVUM CANNABIS AG (27N0.DE) stock traded?

27N0.DE stock is listed on the Frankfurt Stock Exchange exchange.


What is the Price/Earnings (PE) ratio of CANNOVUM CANNABIS AG (27N0.DE)?

CANNOVUM CANNABIS AG (27N0.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).


27N0.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to 27N0.DE. When comparing the yearly performance of all stocks, 27N0.DE turns out to be only a medium performer in the overall market: it outperformed 44.44% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

27N0.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to 27N0.DE. The financial health of 27N0.DE is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

27N0.DE Financial Highlights

Over the last trailing twelve months 27N0.DE reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS decreased by -96.4% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -19.74%
ROE -28.97%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%10.3%
Sales Q2Q%N/A
EPS 1Y (TTM)-96.4%
Revenue 1Y (TTM)-67.86%

27N0.DE Forecast & Estimates

For the next year, analysts expect an EPS growth of 89.29% and a revenue growth 100% for 27N0.DE


Analysts
Analysts82.86
Price TargetN/A
EPS Next Y89.29%
Revenue Next Year100%

27N0.DE Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A